Imbed

Imbed Biosciences is a privately held medical device company specializing in advanced wound care and tissue regeneration solutions. The company's proprietary SAMatrix™ (Synthetic Antimicrobial Matrix) platform technology integrates multiple therapeutic agents, such as antimicrobial silver, gallium, and lidocaine, into ultra-thin, bioresorbable synthetic polymer matrices. Its commercial product portfolio includes Microlyte® for chronic wounds, Surgaflex® for surgical wounds, and Pelashield® for burn and trauma wounds, alongside their respective PainGuard® formulations that incorporate lidocaine for localized pain relief. Imbed's fully synthetic matrices conform to wound micro-textures, eliminate the infection risks associated with animal-derived skin substitutes, and do not require removal, significantly improving patient outcomes and clinical workflows.